Ardelyx, Inc. provided earnings guidance for the full year 2023. For the year, the company expects U.S. net product revenue for IBSRELA to be between $76.0 and $78.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.85 USD | +0.77% | -7.43% | +26.61% |
05-09 | Ardelyx Insider Sold Shares Worth $2,522,217, According to a Recent SEC Filing | MT |
05-09 | Ardelyx Insider Sold Shares Worth $1,831,503, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.61% | 1.82B | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- ARDX Stock
- News Ardelyx, Inc.
- Ardelyx, Inc. Provides Earnings Guidance for the Full Year 2023